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Abstract
Osteoporosis is the most common metabolic bone disease and goes largely undiagnosed throughout the world, due to the inaccessibility of
DXA machines. Multivariate analyses of serum bone turnover markers were evaluated in 226 Orange County, California, residents with the
intent to determine if serum osteocalcin and serum pyridinoline cross-links could be used to detect the onset of osteoporosis as effectively as
a DXA scan. Descriptive analyses of the demographic and lab characteristics of the participants were performed through frequency, means
and standard deviation estimations. We implemented logistic regression modeling to find the best classification algorithm for osteoporosis.
All calculations and model building steps were carried out using R statistical language. Through these analyses, a mathematical algorithm
with diagnostic potential was created. This algorithm showed a sensitivity of 1.0 and a specificity of 0.83, with an area under the Receiver
Operating Characteristic curve of 0.93, thus demonstrating a high predictability for osteoporosis. Our intention is for this algorithm to be
used to evaluate osteoporosis in locations where access to DXA scanning is scarce.

Introduction

they have normal bone density, below-normal bone density
(a condition known as osteopenia) or are osteoporotic [7].
Without DXA scanning, individuals are unaware of this
bone disease until they are faced with a fragility fracture [8].
The World Health Organization predicts that the number of
osteoporotic fractures in men and women is certain to increase
by more than 3-fold over the next fifty years [9]. There has
been a definitive increase in awareness of the disease in
developing countries, where accessibility to DXA scanning is
limited. The most recent data portraying the global distribution
of DXA machines highlights this inaccessibility: only 450
DXA machines in China, for a population of 1.3 billion (1
per 289,000) [10]. Only 34 machines exist in Indonesia, for a
population of 237 million (1 per 7 million) and 161 machines
in Chile, for a population of 17.62 million (1 per 109,000)
[10]. The United States has approximately 35.8 DXA machines
per million of the population (1 per 28,000), compared to a
mere 2.3 machines per million of the population in Peru (1 per
435,000) [10]. These examples illustrate the inequity of DXA
scanner distribution around the world, directly correlating to
an inequity of osteoporosis diagnoses.

Bone remodeling is a dynamic and life-long process that
involves the resorption of mineralized bone by osteoclasts
and the formation of bone matrix by osteoblasts [1]. Skeletal
integrity is maintained through the systemic and local
regulation of this bone remodeling process [2]. Among healthy
adults, this process maintains parity between bone resorption
and bone formation. Osteoporosis is caused by a disequilibrium
of the bone remodeling process, leading to weak and porous
bones [2]. Osteoporosis impedes an individual’s life with a
host of disorders and body changes that include, but are not
limited to, intervertebral bone mass loss leading to reduced
height, compromised posture, chronic pain, limited mobility
and, most severely, bone fractures [3]. It is by far the most
common metabolic bone disease, affecting over 200 million
people worldwide and often has the secondary manifestation
of being an economic burden on the individual and society
[4]. Almost one quarter of osteoporosis diagnoses (44 million)
come solely from the United States of America, a country that
contributes to only 4.3% of the global population [5].
The most definitive method of diagnosing osteoporosis is
through the use of Dual-energy X-ray Absorptiometry (DXA)
[6]. Currently, DXA scanning is known as the gold standard
for measuring bone mineral density (BMD), in which a low
BMD is indicative of osteoporosis [7]. DXA findings are
measured in mass per area (g/cm3) and use the average of an
individual’s BMD from various body locations to generate a
T-score and a Z-score [6]. Based on these statistical measures
of variance from age-adjusted means, one can determine if
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DXA scanning, while it is the current model for determining
patient bone health, is a relatively new procedure, which
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participate in a study to determine the bone health of Orange
County residents. Of these 555 subjects, data from 226
individuals were included in this study. This population
represented individuals belonging to four self-described ethnic
groups: Asian, African American, Caucasian and Hispanic.
After the subjects were categorized by ethnicity and sex, they
were then allocated to age divisions where potential changes in
bone health were expected. An individual’s bone health peaks
around the age of 30 years [17]. After this age, the process
of bone remodeling begins to favor resorption and bone mass
gradually decreases [18]. Additionally, when women begin
menopause at around the age of 50, their bone mass decreases
at a much quicker rate than premenopausal declines [19-21].

began clinical use in the mid-1980’s. The evolution of bonescanning technology has significantly changed from early
methods of X-ray detection (requiring 30% bone loss for
visual recognition) to photon absorptiometry methods and
finally to DXA technology, in which patient bone health can
be recognized and classified for BMD as normal, osteoporotic,
or osteopenic [11]. However, the fulcrum regarding the
advances in technology, which have provided quick and
accurate diagnoses for patient bone health, resides with the
inaccessibility of this technology. Additionally, maintaining a
DXA may be expensive. The latest DXA scanners, equipped
with the World Health Organization Fracture Risk Assessment
(FRAX) calculation tool, cost over $100,000 U.S. per
machine, making them inaccessible to a majority of the global
population [8]. As a result of the economic obstacles faced by
developing nations, there is a need to establish an alternative
form of diagnostic treatment for metabolic diseases, which
may be found by examining specific bone turnover markers
within the blood serum.

Sample Demographics
The 226 subjects that met the inclusion criteria (no prior history
of bone disorders, no bisphosphonates) for this study resided
in Orange County, California. The majority were female
(76.1%), older than 50 years of age (59.5%), with normal BMI
values between 18.5 and 24.9 (57.5%). The average height and
weights of the participants were 65.5 inches and 149.2 pounds
with standard deviations of 3.5 inches and 31.2 pounds.
Moreover, the average serum OC and serum PYD levels were
8.7 nmol/L and 6.6 nmol/L with standard deviations of 3.5 and
3.3. Slightly over half (55.3%) had healthy T-scores greater
than or equal to -1, 41.6% had T-scores between -1 and -2.5
and 3.1% had scores below -2.5, reflecting the diagnosis of
osteoporosis. Descriptive analysis of the sample demographics
and lab characteristics are presented in Table 1.

Bone Turnover Markers
A DXA scan measures and records the density of the bone,
which is dependent upon the activity levels of osteoclasts
and osteoblasts. Osteoclasts remove mineralized bone tissue,
primarily protein and collagen, by secreting an acid containing
specialized proteinases that degrade the organic matrix, which
is re-circulated into the bloodstream [12]. Osteoblasts add
protein and collagen back to bone to create the bone matrix
[13,14]. The activity of these cells correlates to certain
biochemical markers in the blood, known as bone turnover
markers (BTMs) [15]. Therefore, the relative concentrations
of BTMs may effectively contribute to the diagnosis of
osteoporosis. Serum pyridinoline cross-links (s-PYD) and
serum osteocalcin (s-OC) are known BTMs that correlate to
osteoclast and osteoblast activity. They are among the least
expensive assays to obtain, making them the most globally
accessible. BTMs can be measured with specific blood assays
through a simple blood draw [16].

Procedure and Tests Performed
Subjects were randomly recruited from the general Orange
Characteristic:
1) Age (years):
16-30
31-50
51-70
Greater than 70
2) Sex:
Female
Male
3) BMI
Less than 18.5
18.5-24.9
25-29.9
More than 30
4) Height (inches)
5) Weight (pounds)
6) Serum OC (nmol/L)
7) Serum PYD (nmol/L)
8) T-score
-2.5 and below
-1 to -2.5
-1 and above

DXA machine availability in developing countries is simply
too scarce to provide adequate screening for bone health. The
potential for diagnosing osteoporosis through a more simple
blood draw and serum analysis, instead of through use of a
DXA scan, provides important implications for the global
community, especially in regions where DXA scanning is not
available. Blood testing is already widely used around the
world, relatively easy and does not require expensive on-site
machinery. Blood samples could be sent to centralized medical
laboratories for analysis and then these data could be relayed
back to where it originated.
The purpose of this study was to determine the diagnostic
potential of various BTMs—specifically serum OC and serum
PYD—with the intention of creating a cost-effective and
predictive algorithm for the diagnosis of osteoporosis.

Methods
Subject Enrollment

27 (11.9)
56 (24.8)
110 (48.7)
24 (10.8)
172 (76.1)
54 (23.9)
9 (4.0)
130 (57.5)
65 (28.8)
22 (9.7)
65.5 (3.5)
149.2 (31.2)
8.7 (3.5)
6.6 (3.3)
7 (3.1)
94 (41.6)
125 (55.3)

Table 1: Summary statistics of demographics and lab
characteristics of the study participants (N=226).

Over a three-year period, 555 subjects were recruited to
Bone Muscle
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classification purposes of the model, the interpretation of the
logistic regression coefficients shows that a one unit increase
in the serum OC and serum PYD levels were associated with
47% increase and 37% decrease in the odds of osteoporosis
respectively. Similarly, a one-year increase in age is associated
with an 8% increase in the odds of osteoporosis. Detailed
summary results from the best classification model that we
identified are shown in Table 2 and Figure 1.

County population after review and approval of the study
protocol by the Chapman University Institutional Review
Board. The subjects responded to advertisements in papers,
flyers sent to athletic and religious organizations, posters
presented in the windows of local stores, advertisements in
newspapers, advertisements on various Internet websites
and through direct contact. Demographic questions allowed
the subjects to categorize themselves by ethnicity, sex and
age. They also answered lifestyle questions, which were
necessary to calculate the FRAX values [22]. After obtaining
an informed consent, the subjects were sent to Marathon
Medical Group clinic, heights and weights were measured,
blood was drawn and DXA analyses were conducted.
The DXA scan for each subject included analysis of the
femoral neck, trochanter and the intertrochanteric regions
of the femoral diaphysis, which taken together constituted
the total hipbone mineral content. The anterio-posterior
lumbar spine was also assessed. The DXA scans were
performed using two effective energies of 38kW and 70kW.
The BMD data obtained from the DXA reports were utilized
to determine each individual’s T-Score. By convention, a
T-score of -1 or above is considered normal bone density, a
score between -1.0 and -2.5 indicates an osteopenic state and
a score of -2.5 or below is indicative of osteoporosis [23,24].
The blood samples taken at Marathon Medical Group clinic
were sent to Quest Diagnostics and Chapman University for
analysis of specific biomarkers.

Classification of algorithm
The proposed classification algorithm that optimally assigns
people to either the group with or without osteoporosis, given
the values of serum OC, serum PYD and age is based on the
model presented in Table 2. This model predicts log-odds of
having osteoporosis and is given by:
Equation 1
Similarly, the model predicted probability of having
osteoporosis is:

Equation 2
Variable
Intercept
Serum OC
Serum PYD
Age in years

Participants’ body mass index (BMI) scores were also obtained.
After the collection and organization of data, multivariate
statistical analyses were performed.

Estimate Odd Ratio
-9.20
0.39
1.47
-0.45
0.63
0.08
1.08

SE Z-value P-value
2.69 -3.41 0.0006
0.12 3.19
0.001
0.27 -1.70
0.09
0.03 2.22
0.03

Table 2: Summary results from the best classification logistic
regression model.

Statistical Analysis
Demographic and lab characteristics of the study participants
were analyzed through frequency, means and standard deviation
estimations. We implemented logistic regression modeling
to find the best classification algorithm for osteoporosis. All
calculations and model building steps were carried out using R
statistical language.

Results
Logistic regression modeling
We implemented exhaustive logistic regression modeling
by comparing all possible univariate and multivariate
models with and without interactions to identify the model
with the best classification properties with respect to the
presence and absence of osteoporosis given the collected
set of covariates.
The best classification model that was created included main
effects of serum OC with effect size of 0.39 and p-value of
0.001, serum PYD with effect size of -0.45 and p-value of 0.09
and age with effect size of 0.08 and p-value of 0.03. Inclusion of
the marginally significant variable of serum PYD in the model
was justified by the increase of the area under the Receiver
Operating Characteristic (ROC) curve (from 0.89 to 0.93) and
a decrease in the Akaike Information Criterion (AIC) statistic
(from 54.15 to 52.41). Even though unimportant for the
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Figure 1: ROC Curve depicting the best classification model
found through analysis of age, serum OC and serum PYD.
An area under the curve (AUC) of 0.93 was calculated for
this model. The AUC is arguably the best way to summarize
the performance of a predictive model, of which an AUC
close to 1 indicates a highly predictive model and a value at
or below 0.5 indicates a model that is not predictive.
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communities. Disparities in healthcare access are evident in
many global locations, even outside of prototypical Western
cultures (e.g. United States of America), such as the existing
disparity between countries like Israel and Egypt. Per the CIA
World Factbook, Israel (7.80% GDP) ranks 60 spots higher
in global rankings than Egypt (5.60%) in relative promotion,
restoration and maintenance of health (indicated by health
expenditures as a percentage of country GDP) [28]. Given
this information, Israel would be an example of a non-Western
nation with relatively high health standards and priority in
comparison to neighboring Egypt. Israel is home to Holocaust
survivors, who were typically malnourished at an early age,
often a precursor for early onset osteoporosis [29]. Yet,
impacts from malnutrition on bone health in Israel are less
adverse due to higher healthcare priority and accessibility [29].
However, it is unlikely that similar testing practices would be
conducted in countries with higher rates of early malnutrition
and community-wide poverty, such as Africa and Southeast
Asia [30].

The values generated by Equation 2 are between 0 and 1
and subjects with high model predicted probabilities were
assigned to the group with osteoporosis and the rest to the
control group. The threshold that separated high and low
predicted probabilities was chosen optimally so that there
was simultaneously maximized sensitivity and specificity of
the classification algorithm. The threshold that maximized the
sum of the sensitivity and specificity was 0.035. It achieved
sensitivity of 1.0 and specificity of 0.83 and it is denoted with
a diamond on the ROC curve presented in Figure 1. Thus, the
model predicted disease status given serum OC, serum PYD
and age was assigned according to the following classification
rule:
Equation 3

Discussion
Analysis of bone turnover markers indicative of bone
formation and bone resorption proved to be encouraging in the
creation of a diagnostic algorithm (Chapman Bone Algorithm)
for the detection of osteoporosis. When analyzed with age,
concentrations of serum OC and PYD had a direct correlation
to a T-score of -2.5 or lower. Based on the significant
outcome of the multivariate statistical analyses, as well as
the extensively-studied physiology of the bone remodeling
process, we believe that the variables of age, serum OC
and serum PYD are sufficient in detecting osteoporosis.
We initially expected that BMI would be a significant
contributor to the Chapman Bone Algorithm (CBA). Women
with low BMIs are characterized as having weaker bones that
are more susceptible to fractures, while the bones of women
with high BMIs must be proportionately stronger in order to
support a greater body mass [25]. The analysis of BMI in this
data set, however, was not statistically significant (P> 0.05).
Knowing that osteoporosis affects females 4 times more than
males, on cursory examination it might appear that biological
sex was overlooked in the CBA [26,27]. While there is a high
correlation between sex and bone-health predictors of age, OC
and PYD, our statistical model examined direct predictors and
not simply correlational relationships. For this reason, sex is
not explicit in the Chapman Bone Algorithm.

Aside from being a chronic condition that affects those with
low BMD, osteoporosis has also shown comorbid association
with various other chronic health conditions, posing serious
implications on the metabolic bone disease. In conjunction
with HIV, however, limited research on its relationship with
HIV has been conducted. The potential correlation between
HIV prevalence and metabolic bone disease prevalence is
largely unknown, but it may be due to the fact that areas with
high HIV prevalence (e.g. Africa) also have limited resources
for health screening [31]. Potential comorbid diseases
with osteoporosis listed in the literature include ischemic
cardiovascular disease (CVD) and HIV. Common factors
between the CVD and osteoporosis are estrogen deprivation
in women, smoking, low physical activity, or diabetes [32].
Due to the severity of these primitive potential relationships,
establishing medical practices for determining early onset
of osteoporosis, among other chronic metabolic conditions,
is imperative to eliminating health disparities in regions
with limited resources and lack of modern medical practice
feasibility.
Although it may currently be the most common way to diagnose
osteoporosis, DXA scanning is still largely inconvenient,
inaccessible and requires expensive instrumentation
worldwide. We are suggesting an alternative diagnosis for this
bone disease, in which quantitative, statistically-significant
risk factors are utilized in the CBA to determine an individual’s
bone health. We imagine the CBA to not only serve in the
evaluation of osteoporosis but to also provide periodic
evaluations to assess the efficacy of a treatment plan. Instead
of relying on expensive DXA equipment, the Chapman Bone
Algorithm utilizes easily obtained and commonly assayed
biomarkers. We believe the CBA will have similar functionality
to the American Heart Association’s 10-year risk calculator
for developing atherosclerotic cardiovascular disease; which
indicates the likelihood of developing atherosclerosis [33]. It is

In future studies, patient information will be collected using
the same multivariate statistical analyses as described in
this study on larger data sets containing a greater number of
confirmed diagnoses of osteoporosis. Ultimately, the goal of
these future studies will be to test the CBA’s reliability on a
larger data set. Additionally, the utilization of more variables
or the testing of other bone turnover markers could contribute
to a stronger predictive model.
Significance of the CBA
General implications of the CBA lie within the algorithm’s
nature for quick and cost-effective analysis of bone health,
which can be of particular benefit in low socioeconomic
conditions of developed nations or within developing
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likely that the CBA will be an economical, effective and vastly
more accessible diagnostic option for remote and developing
populations and that healthcare providers around the world
can use this algorithm with confidence.

hypertrophic cartilage degradation during long bone development
and growth. Dev Biol 393: 57-70. [View Article].
16. Allende-Vigo MZ, Rosen CJ (2007) The use of biochemical
markers of bone turnover in osteoporosis. P R Health Sci J 26:
91-95. [View Article].
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